ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering – GlobeNewswire

ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering GlobeNewswire

EDISON, N.J., June 18, 2019 (GLOBE NEWSWIRE) — ContraVir Pharmaceuticals, Inc. (“ContraVir,” the “Company,” “we,” “our” or “us”) (NASDAQ:CTRV), …